| Identification | Back Directory | [Name]
4H-Pyrazolo[1,5-a]pyrrolo[3,4-d]pyrimidine-4-acetamide, N-(5-chloro-2-pyridinyl)-5,6,7,8-tetrahydro-6-[(1R)-1-methylpropyl]-5,8-dioxo-2-(trifluoromethyl)- | [CAS]
2310263-59-1 | [Synonyms]
P2X3 antagonist 36
4H-Pyrazolo[1,5-a]pyrrolo[3,4-d]pyrimidine-4-acetamide, N-(5-chloro-2-pyridinyl)-5,6,7,8-tetrahydro-6-[(1R)-1-methylpropyl]-5,8-dioxo-2-(trifluoromethyl)- | [Molecular Formula]
C20H18ClF3N6O3 | [MOL File]
2310263-59-1.mol | [Molecular Weight]
482.84 |
| Hazard Information | Back Directory | [Uses]
P2X3 antagonist 36 is a P2X3 antagonist extracted from patent WO2019081343A1 compound 156[1]. | [References]
[1] Koppitz M, et, al. Novel pyrazolo-pyrrolo-pyrimidine-dione derivatives as p2x3 inhibitors. WO2019081343A1. |
|
|